For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
Performs technical laboratory activities in support of client studies or procedures. Performs analysis of data for quality and completeness and determines if results are as expected. Records data in compliance with company and regulatory policies and standards to meet quality and accuracy requirements.
We are seeking an Analyst in Genetic Toxicology for our Safety Assessment site located at Senneville, QC.
Perform the techniques of Bacterial Mutation Test (BMT), Chromosome Aberration Test (CAT), InVitro Micronucleus (IVM), Mammalian Cell Mutation Test (MCM), Micronucleus Test (MNT) and Comey assay, Cytotoxicity Test by Mode of Action Assay (MOA).
Analysis of bacterial cultures and of cells; processing of animal organs.
Collect and process data in accordance with the GLPs.
Documentation of activities and data analysis.
Work in collaboration with the scientific staff.
Possesses a DEC or a B.Sc in Sciences.
Has experience in analysis of biological samples.
Is flexible and able to rapidly adapt to changes.
Is meticulous, autonomous, reliable and organized.
Is able to do team work.
About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.